Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Challenges in developing a pediatric RSV vaccine

1 Sept 2009

Abstract excerpt

RSV bronchiolitis is the leading cause of infant hospitalization in industrialized countries. There is an unmet need to prevent RSV lower respiratory tract infection in young infants. Although many vaccinology approaches, including live attenuated, viral and bacterial vectored and adjuvanted subunit vaccines have been evaluated in rodent and primate models there is currently no approved RSV vaccine. A vaccine...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Congenital Diaphragmatic Hernia Studies
Share to Neonatal Respiratory Health Research
Share to Respiratory viral infections research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 19556888
DOI: 10.4161/hv.9131

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Challenges in developing a pediatric RSV vaccinePMID 19556888Read ↗

The long road to protect infants against severe RSV lower respiratory tract illnessSemantic proximity Read ↗

A Parainfluenza Virus Vector Expressing the Respiratory Syncytial Virus (RSV) Prefusion F Protein Is More Effective than RSV for Boosting a Primary Immunization with RSV.Semantic proximity Read ↗

Live-Attenuated Respiratory Syncytial Virus Vaccine With M2-2 Deletion and With Small Hydrophobic Noncoding Region Is Highly Immunogenic in ChildrenSemantic proximity Read ↗

RSV--a substantial slice of the airway disease burden and the way to a vaccine.Semantic proximity Read ↗

Current status of respiratory syncytial virus (RSV) and parainfluenza virus type 3 (PIV3) vaccine development: memorandum from a joint WHO/NIAID meeting.Semantic proximity Read ↗

Biology of Infection and Disease Pathogenesis to Guide RSV Vaccine DevelopmentSemantic proximity Read ↗

Current status of vaccines for parainfluenza virus infections.Semantic proximity Read ↗

A Safe and Effective Mucosal RSV Vaccine Consisting of RSV Phosphoprotein and Flagellin VariantSemantic proximity Read ↗

New generation live vaccines against human respiratory syncytial virus designed by reverse genetics.Semantic proximity Read ↗

Live-Attenuated Intranasal RSV Vaccine in Infants and ToddlersSemantic proximity Read ↗

New mucosal bivalent live-attenuated vaccine is protective against Human Metapneumovirus and Respiratory Syncytial VirusSemantic proximity Read ↗

Enhanced Neutralizing Antibody Response Induced by Respiratory Syncytial Virus Prefusion F Protein Expressed by a Vaccine CandidateSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.